You are here
Innovative Biotherapies, Inc.
UEI: T5BFF2BJ8SE3
# of Employees: 12
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: No
Award Charts
Award Listing
-
Cell Therapy for Septic Shock
Amount: $1,155,440.00DESCRIPTION (provided by applicant): Tissue engineering and cell therapy is a new and exciting approach to the treatment of acute and chronic diseases. The potential success of this therapeutic approa ...
SBIRPhase II2008Department of Health and Human Services National Institutes of Health -
Renal Tubules for a Bioartificial Kidney: Monolayer Differentiation of ES Cells
Amount: $249,999.00DESCRIPTION (provided by applicant): Over 400,000 people are currently being treated for End-Stage Renal Disease (ESRD) in the United States, with the number of patients expected to grow dramatically ...
SBIRPhase I2007Department of Health and Human Services National Institutes of Health -
Cell Therapy for Septic Shock
Amount: $500,000.00DESCRIPTION (provided by applicant): Tissue engineering and cell therapy are a new and exciting approach to the treatment of acute and chronic diseases. The potential success of this therapeutic appro ...
SBIRPhase I2006Department of Health and Human Services National Institutes of Health